Northwest Biotherapeutics
(OTC) NWBO
Northwest Biotherapeutics Financials at a Glance
Market Cap
$312.14M
Revenue (TTM)
$937.00K
Net Income (TTM)
$90.04M
EPS (TTM)
$-0.07
P/E Ratio
-3.07
Dividend
$0.00
Beta (Volatility)
0.08 (Low)
Dividend
$0.00
Beta (Volatility)
0.08 (Low)
Price
$0.20
Volume
1,236,644
Open
$0.20
Price
$0.20
Volume
1,236,644
Open
$0.20
Previous Close
$0.20
Daily Range
$0.20 - $0.20
52-Week Range
$0.17 - $0.48
Dividend
$0.00
Beta (Volatility)
0.08 (Low)
Price
$0.20
Volume
1,236,644
Open
$0.20
Previous Close
$0.20
Daily Range
$0.20 - $0.20
52-Week Range
$0.17 - $0.48
NWBO News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Northwest Biotherapeutics
Industry
Biotechnology
Sector
Health CareEmployees
25
CEO
Linda F. Powers
Website
www.nwbio.comHeadquarters
Bethesda, MD 20814, US
NWBO Financials
Key Financial Metrics (TTM)
Gross Margin
44%
Operating Margin
-69%
Net Income Margin
-96%
Return on Equity
0%
Return on Capital
1%
Return on Assets
-3%
Earnings Yield
-32.57%
Dividend Yield
0.00%
Payout Ratio
-0.49%
Stock Overview
Market Cap
$312.14M
Shares Outstanding
1.54B
Volume
1.24M
Short Interest
0.00%
Avg. Volume
2.70M
Financials (TTM)
Gross Profit
$1.38M
Operating Income
$66.51M
EBITDA
$73.64M
Operating Cash Flow
$57.02M
Capital Expenditure
$1.01M
Free Cash Flow
$58.03M
Cash & ST Invst.
$2.17M
Total Debt
$67.44M
Northwest Biotherapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$200.00K
-44.0%
Gross Profit
$321.00K
-189.9%
Gross Margin
-1.60%
N/A
Market Cap
$312.14M
N/A
Market Cap/Employee
$12.49M
N/A
Employees
25
N/A
Net Income
$26.83M
-38.5%
EBITDA
$24.04M
-43.3%
Quarterly Fundamentals
Net Cash
$72.49M
-30.9%
Accounts Receivable
$311.00K
N/A
Inventory
$0.00
N/A
Long Term Debt
$36.25M
+23.7%
Short Term Debt
$40.80M
+39.3%
Return on Assets
-2.94%
N/A
Return on Invested Capital
1.13%
N/A
Free Cash Flow
$13.50M
-60.5%
Operating Cash Flow
$13.89M
-68.7%